Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma

Lower-grade glioma (LGG) is a group of tumors arising from the cells of the central nervous system. Although various therapy interventions are used, the prognosis remains different. Novel biomarkers are needed for the prognosis of disease and novel therapeutic strategies in LGG. The procollagen-lysi...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular neuroscience 2022-02, Vol.16, p.838548-838548
Main Authors: Gong, Siming, Wu, Changwu, Köhler, Franziska, Meixensberger, Jürgen, Schopow, Nikolas, Kallendrusch, Sonja
Format: Article
Language:English
Subjects:
Biomarkers
Brain tumors
Cancer
Cellular Neuroscience
Central nervous system
Collagen
Datasets
Disease
Gene expression
Genomes
Glioma
immune infiltration
Immunology
immunotherapy
Ketoglutaric acid
lower-grade glioma
Lysine
Medical prognosis
Metastases
Patients
PLOD family
Procollagen
Procollagen-lysine 5-dioxygenase
Prognosis
Proteins
Software
Survival analysis
Tumor microenvironment
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3
cites cdi_FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3
container_end_page 838548
container_issue
container_start_page 838548
container_title Frontiers in cellular neuroscience
container_volume 16
creator Gong, Siming
Wu, Changwu
Köhler, Franziska
Meixensberger, Jürgen
Schopow, Nikolas
Kallendrusch, Sonja
description Lower-grade glioma (LGG) is a group of tumors arising from the cells of the central nervous system. Although various therapy interventions are used, the prognosis remains different. Novel biomarkers are needed for the prognosis of disease and novel therapeutic strategies in LGG. The procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) family contains three members and is related to multiple cancers, yet it was not investigated in LGG. Data from the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) cohorts were used to analyze the role of PLOD in LGG. As the PLOD family is involved in processes, such as tumor formation and cancer metastasis, we focused on its relationship to the tumor microenvironment (TME) in LGG. A high expression of the PLOD family relates to poor prognosis and high infiltration of immune cells within the TME. The expression level of the PLOD family might become a novel biomarker for prognosis and is a potential target for individual treatment decisions in LGG.
doi_str_mv 10.3389/fncel.2022.838548
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f1135ba052db4e97b7e959f668039179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_f1135ba052db4e97b7e959f668039179</doaj_id><sourcerecordid>2630413349</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3</originalsourceid><addsrcrecordid>eNpdks1u1DAUhSMEoqXwAGyQJTYsyOCfxLFZVIJCh0oDRaisLSe-CR4cu9jJ0HkM3hhPp1QtK1u-53469_oUxXOCF4wJ-ab3HbgFxZQuBBN1JR4Uh4RzWtYE04d37gfFk5TWGHPKK_G4OGA1rXEl8WHx52sMXXBOD-DL1TZZD68RLc-vwuDmSUc9AarLDzZcbbNCJ0CnerRu-xZ9CRtwKLcPPqTJdui9DaOOPyEmpL1BF_MYIvpsuxjAb2wMfgQ_oW8wzE5PIav6XF-F3xDLZdQG0NLtCE-LR712CZ7dnEfF99OPFyefytX58uzk3arsKsmmshKVoLTrsRSs431npCDEADFSMkJBtJjLimGhDQHMOIe2qUXLDO4pYQIbdlSc7bkm6LW6jDab36qgrbp-CHFQOua5HKieEFa3GtfUtBXIpm1A1rLnXGAmSSMz63jPupzbEUyXB43a3YPer3j7Qw1ho4TIJhnOgFc3gBh-zZAmNdqUP9dpD2FOinLGhWgaXmfpy_-k6zBHn1e1U-GKMFbtHJG9Kq8_pQj9rRmC1S486jo8ahcetQ9P7nlxd4rbjn9pYX8B8wLCaw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2630413349</pqid></control><display><type>article</type><title>Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma</title><source>PubMed Central Free</source><creator>Gong, Siming ; Wu, Changwu ; Köhler, Franziska ; Meixensberger, Jürgen ; Schopow, Nikolas ; Kallendrusch, Sonja</creator><creatorcontrib>Gong, Siming ; Wu, Changwu ; Köhler, Franziska ; Meixensberger, Jürgen ; Schopow, Nikolas ; Kallendrusch, Sonja</creatorcontrib><description>Lower-grade glioma (LGG) is a group of tumors arising from the cells of the central nervous system. Although various therapy interventions are used, the prognosis remains different. Novel biomarkers are needed for the prognosis of disease and novel therapeutic strategies in LGG. The procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) family contains three members and is related to multiple cancers, yet it was not investigated in LGG. Data from the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) cohorts were used to analyze the role of PLOD in LGG. As the PLOD family is involved in processes, such as tumor formation and cancer metastasis, we focused on its relationship to the tumor microenvironment (TME) in LGG. A high expression of the PLOD family relates to poor prognosis and high infiltration of immune cells within the TME. The expression level of the PLOD family might become a novel biomarker for prognosis and is a potential target for individual treatment decisions in LGG.</description><identifier>ISSN: 1662-5102</identifier><identifier>EISSN: 1662-5102</identifier><identifier>DOI: 10.3389/fncel.2022.838548</identifier><identifier>PMID: 35250490</identifier><language>eng</language><publisher>Switzerland: Frontiers Research Foundation</publisher><subject>Biomarkers ; Brain tumors ; Cancer ; Cellular Neuroscience ; Central nervous system ; Collagen ; Datasets ; Disease ; Gene expression ; Genomes ; Glioma ; immune infiltration ; Immunology ; immunotherapy ; Ketoglutaric acid ; lower-grade glioma ; Lysine ; Medical prognosis ; Metastases ; Patients ; PLOD family ; Procollagen ; Procollagen-lysine 5-dioxygenase ; Prognosis ; Proteins ; Software ; Survival analysis ; Tumor microenvironment</subject><ispartof>Frontiers in cellular neuroscience, 2022-02, Vol.16, p.838548-838548</ispartof><rights>Copyright © 2022 Gong, Wu, Köhler, Meixensberger, Schopow and Kallendrusch.</rights><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2022 Gong, Wu, Köhler, Meixensberger, Schopow and Kallendrusch. 2022 Gong, Wu, Köhler, Meixensberger, Schopow and Kallendrusch</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3</citedby><cites>FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894330/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894330/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35250490$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gong, Siming</creatorcontrib><creatorcontrib>Wu, Changwu</creatorcontrib><creatorcontrib>Köhler, Franziska</creatorcontrib><creatorcontrib>Meixensberger, Jürgen</creatorcontrib><creatorcontrib>Schopow, Nikolas</creatorcontrib><creatorcontrib>Kallendrusch, Sonja</creatorcontrib><title>Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma</title><title>Frontiers in cellular neuroscience</title><addtitle>Front Cell Neurosci</addtitle><description>Lower-grade glioma (LGG) is a group of tumors arising from the cells of the central nervous system. Although various therapy interventions are used, the prognosis remains different. Novel biomarkers are needed for the prognosis of disease and novel therapeutic strategies in LGG. The procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) family contains three members and is related to multiple cancers, yet it was not investigated in LGG. Data from the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) cohorts were used to analyze the role of PLOD in LGG. As the PLOD family is involved in processes, such as tumor formation and cancer metastasis, we focused on its relationship to the tumor microenvironment (TME) in LGG. A high expression of the PLOD family relates to poor prognosis and high infiltration of immune cells within the TME. The expression level of the PLOD family might become a novel biomarker for prognosis and is a potential target for individual treatment decisions in LGG.</description><subject>Biomarkers</subject><subject>Brain tumors</subject><subject>Cancer</subject><subject>Cellular Neuroscience</subject><subject>Central nervous system</subject><subject>Collagen</subject><subject>Datasets</subject><subject>Disease</subject><subject>Gene expression</subject><subject>Genomes</subject><subject>Glioma</subject><subject>immune infiltration</subject><subject>Immunology</subject><subject>immunotherapy</subject><subject>Ketoglutaric acid</subject><subject>lower-grade glioma</subject><subject>Lysine</subject><subject>Medical prognosis</subject><subject>Metastases</subject><subject>Patients</subject><subject>PLOD family</subject><subject>Procollagen</subject><subject>Procollagen-lysine 5-dioxygenase</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>Software</subject><subject>Survival analysis</subject><subject>Tumor microenvironment</subject><issn>1662-5102</issn><issn>1662-5102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdks1u1DAUhSMEoqXwAGyQJTYsyOCfxLFZVIJCh0oDRaisLSe-CR4cu9jJ0HkM3hhPp1QtK1u-53469_oUxXOCF4wJ-ab3HbgFxZQuBBN1JR4Uh4RzWtYE04d37gfFk5TWGHPKK_G4OGA1rXEl8WHx52sMXXBOD-DL1TZZD68RLc-vwuDmSUc9AarLDzZcbbNCJ0CnerRu-xZ9CRtwKLcPPqTJdui9DaOOPyEmpL1BF_MYIvpsuxjAb2wMfgQ_oW8wzE5PIav6XF-F3xDLZdQG0NLtCE-LR712CZ7dnEfF99OPFyefytX58uzk3arsKsmmshKVoLTrsRSs431npCDEADFSMkJBtJjLimGhDQHMOIe2qUXLDO4pYQIbdlSc7bkm6LW6jDab36qgrbp-CHFQOua5HKieEFa3GtfUtBXIpm1A1rLnXGAmSSMz63jPupzbEUyXB43a3YPer3j7Qw1ho4TIJhnOgFc3gBh-zZAmNdqUP9dpD2FOinLGhWgaXmfpy_-k6zBHn1e1U-GKMFbtHJG9Kq8_pQj9rRmC1S486jo8ahcetQ9P7nlxd4rbjn9pYX8B8wLCaw</recordid><startdate>20220218</startdate><enddate>20220218</enddate><creator>Gong, Siming</creator><creator>Wu, Changwu</creator><creator>Köhler, Franziska</creator><creator>Meixensberger, Jürgen</creator><creator>Schopow, Nikolas</creator><creator>Kallendrusch, Sonja</creator><general>Frontiers Research Foundation</general><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220218</creationdate><title>Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma</title><author>Gong, Siming ; Wu, Changwu ; Köhler, Franziska ; Meixensberger, Jürgen ; Schopow, Nikolas ; Kallendrusch, Sonja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomarkers</topic><topic>Brain tumors</topic><topic>Cancer</topic><topic>Cellular Neuroscience</topic><topic>Central nervous system</topic><topic>Collagen</topic><topic>Datasets</topic><topic>Disease</topic><topic>Gene expression</topic><topic>Genomes</topic><topic>Glioma</topic><topic>immune infiltration</topic><topic>Immunology</topic><topic>immunotherapy</topic><topic>Ketoglutaric acid</topic><topic>lower-grade glioma</topic><topic>Lysine</topic><topic>Medical prognosis</topic><topic>Metastases</topic><topic>Patients</topic><topic>PLOD family</topic><topic>Procollagen</topic><topic>Procollagen-lysine 5-dioxygenase</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>Software</topic><topic>Survival analysis</topic><topic>Tumor microenvironment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gong, Siming</creatorcontrib><creatorcontrib>Wu, Changwu</creatorcontrib><creatorcontrib>Köhler, Franziska</creatorcontrib><creatorcontrib>Meixensberger, Jürgen</creatorcontrib><creatorcontrib>Schopow, Nikolas</creatorcontrib><creatorcontrib>Kallendrusch, Sonja</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gong, Siming</au><au>Wu, Changwu</au><au>Köhler, Franziska</au><au>Meixensberger, Jürgen</au><au>Schopow, Nikolas</au><au>Kallendrusch, Sonja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma</atitle><jtitle>Frontiers in cellular neuroscience</jtitle><addtitle>Front Cell Neurosci</addtitle><date>2022-02-18</date><risdate>2022</risdate><volume>16</volume><spage>838548</spage><epage>838548</epage><pages>838548-838548</pages><issn>1662-5102</issn><eissn>1662-5102</eissn><abstract>Lower-grade glioma (LGG) is a group of tumors arising from the cells of the central nervous system. Although various therapy interventions are used, the prognosis remains different. Novel biomarkers are needed for the prognosis of disease and novel therapeutic strategies in LGG. The procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD) family contains three members and is related to multiple cancers, yet it was not investigated in LGG. Data from the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) cohorts were used to analyze the role of PLOD in LGG. As the PLOD family is involved in processes, such as tumor formation and cancer metastasis, we focused on its relationship to the tumor microenvironment (TME) in LGG. A high expression of the PLOD family relates to poor prognosis and high infiltration of immune cells within the TME. The expression level of the PLOD family might become a novel biomarker for prognosis and is a potential target for individual treatment decisions in LGG.</abstract><cop>Switzerland</cop><pub>Frontiers Research Foundation</pub><pmid>35250490</pmid><doi>10.3389/fncel.2022.838548</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1662-5102
ispartof Frontiers in cellular neuroscience, 2022-02, Vol.16, p.838548-838548
issn 1662-5102
1662-5102
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f1135ba052db4e97b7e959f668039179
source PubMed Central Free
subjects Biomarkers
Brain tumors
Cancer
Cellular Neuroscience
Central nervous system
Collagen
Datasets
Disease
Gene expression
Genomes
Glioma
immune infiltration
Immunology
immunotherapy
Ketoglutaric acid
lower-grade glioma
Lysine
Medical prognosis
Metastases
Patients
PLOD family
Procollagen
Procollagen-lysine 5-dioxygenase
Prognosis
Proteins
Software
Survival analysis
Tumor microenvironment
title Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase Family: Novel Prognostic Biomarkers and Tumor Microenvironment Regulators for Lower-Grade Glioma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Procollagen-Lysine,%202-Oxoglutarate%205-Dioxygenase%20Family:%20Novel%20Prognostic%20Biomarkers%20and%20Tumor%20Microenvironment%20Regulators%20for%20Lower-Grade%20Glioma&rft.jtitle=Frontiers%20in%20cellular%20neuroscience&rft.au=Gong,%20Siming&rft.date=2022-02-18&rft.volume=16&rft.spage=838548&rft.epage=838548&rft.pages=838548-838548&rft.issn=1662-5102&rft.eissn=1662-5102&rft_id=info:doi/10.3389/fncel.2022.838548&rft_dat=%3Cproquest_doaj_%3E2630413349%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-484822cf0983c6fcd9811de1d99312e8b0694308ad1e0366eb758b3d0f21380d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2630413349&rft_id=info:pmid/35250490&rfr_iscdi=true